肠道微生物群对五种肝病的因果影响:从孟德尔随机化和单细胞RNA测序的见解
Na Li1,2, Xuanyi Chen3, Shuai Xiong1,2
1Department of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Frontiers in genetics
|November 26, 2024
概括
肠道微生物群 (GM) 影响肝病风险. 肠道细菌Prevotella对五种肝病具有保护作用,为新疗法提供了潜力.
科学领域:
- 遗传学 是一个遗传学.
- 微生物学 微生物学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 肝病是全球主要的死亡原因之一.
- 新出现的证据表明,肠道微生物群 (GM) 与肝脏健康之间存在重要联系.
- 了解这种关系对于开发有效治疗方法至关重要.
研究的目的:
- 研究肠道微生物群与五种主要肝脏疾病之间的因果关系.
- 探索Prevotella在肝病发展和进展中的特定作用.
- 在肠道微生物群中识别潜在的治疗点.
主要方法:
- 利用两样本的门德尔随机化 (MR) 分析与肠道微生物群的大规模全基因组关联研究数据.
- 来自IEU Open GWAS和NHGRI-EBI GWAS目录的综合肝病数据.
- 采用单细胞RNA测序来分析肝脏组织中与Prevotella相关的基因表达.
主要成果:
- 门德尔随机化分析证实了肠道微生物群组成和肝脏疾病之间的因果关系.
- 普雷沃特拉在所有五种研究肝病中都表现出显著的保护作用,包括酒精性肝病,肝硬化,肝衰竭,良性肝瘤和原发性恶性肝瘤.
- 单细胞RNA测序揭示了与健康个体相比,肝病患者的Prevotella相关基因的差异表达.
结论:
- 这项研究确立了肠道微生物群和肝脏疾病之间的因果关系.
- 普雷沃特拉 (Prevotella) 成为一个关键的保护因素,表明其治疗潜力.
- 这些发现为增强的微生物向治疗和肝病学新临床研究方向铺平了道路.
相关概念视频
01:22Introduction to the Human Microbiota
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...